SynthesisNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025
Efficacy of various acupuncture modalities on alleviating symptoms in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.
Synthesis in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Acupuncture: A Promising Non-Pharmacological Approach to Parkinson's Disease Management.Brain and behavior · 2026Review
- Integrative perspectives on electroacupuncture modulation of vagal-cholinergic and neuro-immune-metabolic regulation in long COVID.Frontiers in integrative neuroscience · 2026Review
- Efficacy of Acupuncture for Pain in Parkinson's Disease: Study Protocol for a Randomized Controlled Trial.Journal of pain research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundParkinson's disease (PD) is a progressive neurological condition, that often respond poorly to conventional treatments. Acupuncture has gained attention as a supportive therapy, but the clinical effects of its various modalities remain insufficiently defined. This study examined the therapeutic efficacy of different acupuncture approaches in managing symptoms of PD.
methodsThe meta-analysis and systematic review was carried out in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD42024627483). Randomized controlled trials (RCTs) assessing acupuncture modalities combined with standard PD therapy was encompassed. The Cochrane RoB 2 tool was utilized to figure out the risk of bias, and subgroup/meta-regression analyses explored heterogeneity. Evidence certainty was rated using the GRADE framework.
resultsIn 50 RCTs (n = 3,248), acupuncture significantly outperformed Western medicine across all UPDRS domains, with the strongest effect on treatment-related motor complications (SMD: -2.16; 95% CI: -3.10 to -1.22). It also improved quality of life, pain, sleep, depression, and anxiety. Optimal results were linked to ≥ 10 acupoints, moderate session duration, and thrice-weekly treatment. Among all modalities, electroacupuncture showed the highest overall efficacy. Thinner needles worked better for non-motor symptoms; thicker ones favored motor outcomes. No serious adverse events occurred; mild effects were rare and transient.
conclusionsThis comprehensive analysis highlights acupuncture-especially electroacupuncture-as a clinically valuable adjunct to standard PD therapy. Its benefits across motor, non-motor, and psychological domains, when delivered with optimized parameters, suggest a strong case for its integration into personalized PD management strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.